4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-15-055198
Chief Executive Officer sold 5,200 shares at an average $54.72 ($284,545)
From the SEC's structured data for this filing
Trades in this filing
Ciechanover Isaac E. · Chief Executive Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2015-06-17 | Sale : show line 1 in the form | −2,000 | $54.86 | $109,720 | 398,982 | I |
| 2015-06-17 | Sale : show line 2 in the form | −600 | $55.60 | $33,360 | 398,382 | I |
| 2015-06-18 | Sale : show line 3 in the form | −700 | $52.62 | $36,834 | 397,682 | I |
| 2015-06-18 | Sale : show line 4 in the form | −900 | $53.83 | $48,447 | 396,782 | I |
| 2015-06-18 | Sale : show line 5 in the form | −700 | $55.77 | $39,039 | 396,082 | I |
| 2015-06-18 | Sale : show line 6 in the form | −300 | $57.15 | $17,145 | 395,782 | I |
| Open-market sales · 5,200 sh · avg $54.72 · $284,545 | ||||||
Loading xslF345X03/doc4.xml…